Gene: OSGEPL1
Official Full Name: O-sialoglycoprotein endopeptidase like 1provided by HGNC
Gene Summary: Enables N(6)-L-threonylcarbamoyladenine synthase activity. Involved in tRNA threonylcarbamoyladenosine modification. Is active in mitochondrion. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO15431 | OSGEPL1 Knockout cell line (HeLa) | Human | OSGEPL1 | 1:3~1:6 | Negative | Online Inquiry |
KO15432 | OSGEPL1 Knockout cell line (HCT 116) | Human | OSGEPL1 | 1:2~1:4 | Negative | Online Inquiry |
KO15433 | OSGEPL1 Knockout cell line (HEK293) | Human | OSGEPL1 | 1:3~1:6 | Negative | Online Inquiry |
KO15434 | OSGEPL1 Knockout cell line (A549) | Human | OSGEPL1 | 1:3~1:4 | Negative | Online Inquiry |
OSGEPL1 Gene Knockout Cell Lines are specialized cellular models developed for the comprehensive analysis of gene function, specifically targeting the OSGEPL1 gene, which is associated with essential biological processes, including cellular signaling and metabolic pathways. These knockout cell lines serve as invaluable tools for researchers investigating gene-specific roles in various physiological and pathological contexts, offering a unique platform to study knockdown effects at both cellular and molecular levels.
The OSGEPL1 knockout mechanism involves precise gene editing techniques, such as CRISPR-Cas9 or homologous recombination, which enable the disruption of the OSGEPL1 gene. This results in the loss of function of the encoded protein, allowing scientists to elucidate the consequences of OSGEPL1 disruption on cellular behavior, including proliferation, differentiation, and response to stimuli. By observing these changes, researchers can better understand disease mechanisms and potential therapeutic targets.
From a scientific standpoint, these knockout cell lines are crucial for advancing research in neurobiology, oncology, and metabolic disorders. They enable high-throughput screening of drug candidates and facilitate the exploration of gene-environment interactions. Clinical applications may also extend to biomarker discovery and the development of personalized medicine strategies, particularly in understanding patient-specific responses to therapies influenced by OSGEPL1 expression.
One of the significant advantages of the OSGEPL1 Gene Knockout Cell Lines is their specificity and robustness compared to traditional knockdown approaches, such as RNA interference, which may exhibit variable efficiency and off-target effects. Furthermore, the cell lines are validated for consistent performance, providing researchers with reliable and reproducible data.
For researchers and clinicians invested in genetics and cellular biology, OSGEPL1 Gene Knockout Cell Lines present a powerful resource for driving discoveries and innovations. By offering these models, our company demonstrates its commitment to advancing scientific inquiry, supported by a team of experts in genetic engineering and cell biology. This product not only facilitates cutting-edge research but also contributes to the broader goal of improving health outcomes through a deepened understanding of gene function.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.